FY2022

October 17, 9:30-10:45 (JST) (planned)

  fezolinetant meeting 

August 1

▶ Announcement of 1Q/FY2022 Financial Results

June 20

The 17th term Annual Shareholders Meeting

April 27

▶ Announcement of FY2021 Financial Results
 

FY2021

March 9, 9:30-11:00 (JST)

▶ R&D Meeting - Initiatives for Gene Therapy-

February 28, 15:00-16:30 (JST)

▶ Sustainability Meeting

February 2

▶ Announcement of 3Q/FY2021 Financial Results

January 21

▶ Online media seminar "Digital Transformation of Astellas Pharma"

December 7

▶ R&D Meeting

October 29

▶ Announcement of 2Q/FY2021 Financial Results

July 30

▶ Announcement of 1Q/FY2021 Financial Results

June 18

▶ The 16th Term Annual Shareholders Meeting

May 26

▶ Information meeting on Strategic Plan 

April 27

▶ Announcement of FY2020 Financial Results
 

FY2020

January 29

▶ Announcement of 3Q/FY2020 Financial Results

December 10

▶ R&D Meeting

October 30

▶ Announcement of 2Q/FY2020 Financial Results

August 4

▶ Announcement of 1Q/FY2020 Financial Results

June 18

▶ The 15th Term Annual Shareholders Meeting

May 14

▶ Announcement of FY2019 Financial Results
 

FY2019

January 31

▶ Announcement of 3Q/FY2019 Financial Results

December 10

▶ R&D Meeting

October 31

▶ Announcement of 2Q/FY2019 Financial Results

October 1

▶ Conference Call

July 30

▶ Announcement of 1Q/FY2019 Financial Results

June 18

▶ The 14th Term Annual Shareholders Meeting

April 25

▶ Announcement of FY2018 Financial Results
 

FY2018

January 31

▶ Announcement of 3Q/FY2018 Financial Results

December 13

▶ R&D Meeting

October 31

▶ Announcement of 2Q/FY2018 Financial Results

July 27

▶ Announcement of 1Q/FY2018 Financial Results

June 15

▶ The 13th Term Annual Shareholders Meeting

May 22

▶ Information meeting on Strategic Plan

April 26

▶ Announcement of FY2017 Financial Results

*Change of the schedule above may occur at anytime without notice.